JP2022513111A5 - - Google Patents

Info

Publication number
JP2022513111A5
JP2022513111A5 JP2021528936A JP2021528936A JP2022513111A5 JP 2022513111 A5 JP2022513111 A5 JP 2022513111A5 JP 2021528936 A JP2021528936 A JP 2021528936A JP 2021528936 A JP2021528936 A JP 2021528936A JP 2022513111 A5 JP2022513111 A5 JP 2022513111A5
Authority
JP
Japan
Prior art keywords
dsrna
sequence
group
ids
sequence ids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021528936A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513111A (ja
JP7707065B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/082216 external-priority patent/WO2020104649A2/en
Publication of JP2022513111A publication Critical patent/JP2022513111A/ja
Publication of JP2022513111A5 publication Critical patent/JP2022513111A5/ja
Application granted granted Critical
Publication of JP7707065B2 publication Critical patent/JP7707065B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021528936A 2018-11-23 2019-11-22 Angptl8を阻害するための新規のrna組成物および方法 Active JP7707065B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18306562 2018-11-23
EP18306562.2 2018-11-23
PCT/EP2019/082216 WO2020104649A2 (en) 2018-11-23 2019-11-22 Novel rna compositions and methods for inhibiting angptl8

Publications (3)

Publication Number Publication Date
JP2022513111A JP2022513111A (ja) 2022-02-07
JP2022513111A5 true JP2022513111A5 (cg-RX-API-DMAC7.html) 2022-11-29
JP7707065B2 JP7707065B2 (ja) 2025-07-14

Family

ID=64564803

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021528936A Active JP7707065B2 (ja) 2018-11-23 2019-11-22 Angptl8を阻害するための新規のrna組成物および方法

Country Status (5)

Country Link
US (1) US12416004B2 (cg-RX-API-DMAC7.html)
EP (1) EP3884051A2 (cg-RX-API-DMAC7.html)
JP (1) JP7707065B2 (cg-RX-API-DMAC7.html)
CN (1) CN113166760A (cg-RX-API-DMAC7.html)
WO (1) WO2020104649A2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113166760A (zh) 2018-11-23 2021-07-23 赛诺菲 用于抑制angptl8的新型rna组合物和方法
US20220372063A1 (en) * 2019-09-05 2022-11-24 Sanofi Oligonucleotides containing nucleotide analogs
PE20250353A1 (es) * 2021-06-24 2025-02-06 Lilly Co Eli Terapeutica con arn novedosos y usos de estos
WO2024138111A1 (en) 2022-12-23 2024-06-27 Eli Lilly And Company Novel rna therapeutics and uses thereof
WO2024160147A1 (zh) * 2023-02-01 2024-08-08 北京福元医药股份有限公司 抑制血管生成素样蛋白8基因表达的siRNA、其缀合物和药物组合物及用途
WO2024227059A2 (en) * 2023-04-27 2024-10-31 Aligos Therapeutics, Inc. Short interfering nucleic acid (sina) molecules targeting angptl 3 and angptl 8 and methods of using the same
WO2025264952A2 (en) 2024-06-21 2025-12-26 Eli Lilly And Company Novel rna therapeutics and uses thereof
CN119367545B (zh) * 2025-01-02 2025-04-08 山东第一医科大学(山东省医学科学院) 靶向干预ANGPTL8 mRNA在制备治疗高同型半胱氨酸血症药物中的应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5665710A (en) 1990-04-30 1997-09-09 Georgetown University Method of making liposomal oligodeoxynucleotide compositions
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
US5587308A (en) 1992-06-02 1996-12-24 The United States Of America As Represented By The Department Of Health & Human Services Modified adeno-associated virus vector capable of expression from a novel promoter
JPH07509133A (ja) 1992-07-17 1995-10-12 リボザイム・ファーマシューティカルズ・インコーポレイテッド 動物疾患の処置のための方法および剤
US5478745A (en) 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
US6054299A (en) 1994-04-29 2000-04-25 Conrad; Charles A. Stem-loop cloning vector and method
JP4335310B2 (ja) 1995-06-07 2009-09-30 ザ ユニバーシティ オブ ブリティッシュ コロンビア 疎水性脂質−核酸複合中間体を通して調製される脂質−核酸粒子、及び遺伝子移送のための使用
US5981501A (en) 1995-06-07 1999-11-09 Inex Pharmaceuticals Corp. Methods for encapsulating plasmids in lipid bilayers
US7422902B1 (en) 1995-06-07 2008-09-09 The University Of British Columbia Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
ATE237312T1 (de) 1998-07-20 2003-05-15 Protiva Biotherapeutics Inc In liposomen verkapselte nukleinsäurekomplexe
BR9914772A (pt) 1998-10-09 2001-12-11 Ingene Inc Conjunto de elementos genéticos, vetor, célulahospedeira, conjunto para a produção de umasequência de ácido nucléico, método para aprodução in vivo ou in vitro de uma sequência deácido nucléico, transcrição de cdna, molécula deácido nucléico inibidor, transcrição de mrna,molécula heteroduplex e composiçãofarmacêutica
AU6298899A (en) 1998-10-09 2000-05-01 Ingene, Inc. Production of ssdna (in vivo)
EP2305813A3 (en) * 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna
CN101583346B (zh) 2006-04-28 2015-08-19 儿童医院医疗中心 用于穿膜药物递送系统的皂化蛋白c和相关蛋白及肽的促融合性质
CN101500548A (zh) 2006-08-18 2009-08-05 弗·哈夫曼-拉罗切有限公司 用于体内递送多核苷酸的多缀合物
EP2319926B1 (en) 2007-07-05 2016-08-31 Arrowhead Research Corporation DSRNA for treating viral infection
EP2229186A2 (en) 2007-12-04 2010-09-22 Alnylam Pharmaceuticals Inc. Carbohydrate conjugates as delivery agents for oligonucleotides
WO2010093788A2 (en) 2009-02-11 2010-08-19 Dicerna Pharmaceuticals, Inc. Multiplex dicer substrate rna interference molecules having joining sequences
EP4253395A3 (en) * 2012-08-06 2023-11-29 Alnylam Pharmaceuticals, Inc. Processes for the preparation of carbohydrate conjugated rna agents
PL2992098T3 (pl) 2013-05-01 2019-09-30 Ionis Pharmaceuticals, Inc. Kompozycje i sposoby modulowania ekspresji hbv i ttr
PL3439689T3 (pl) 2016-04-08 2022-01-31 Regeneron Pharmaceuticals, Inc. Sposoby leczenia hiperlipidemii inhibitorem angptl8 i inhibitorem angptl3
CN112105625B (zh) 2018-03-07 2024-12-31 赛诺菲 核苷酸前体、核苷酸类似物以及含其的寡聚化合物
CN113166760A (zh) 2018-11-23 2021-07-23 赛诺菲 用于抑制angptl8的新型rna组合物和方法
CN115176011B (zh) 2019-08-27 2025-11-11 赛诺菲 用于抑制pcsk9的组合物和方法
US20220372063A1 (en) 2019-09-05 2022-11-24 Sanofi Oligonucleotides containing nucleotide analogs
US20230383294A1 (en) 2020-10-16 2023-11-30 Sanofi Novel rna compositions and methods for inhibiting angptl3
EP4229201A1 (en) 2020-10-16 2023-08-23 Sanofi Rna compositions and methods for inhibiting lipoprotein(a)
US20240092819A1 (en) 2020-10-20 2024-03-21 Sanofi Novel ligands for asialoglycoprotein receptor

Similar Documents

Publication Publication Date Title
JP2022546040A5 (cg-RX-API-DMAC7.html)
JP2022547888A5 (cg-RX-API-DMAC7.html)
JP2019530656A5 (cg-RX-API-DMAC7.html)
JP7249080B2 (ja) 可逆的に修飾されたオリゴヌクレオチドを含む組成物及びその使用
TWI680767B (zh) 用於增強的細胞攝取之化合物及方法
JP2021533804A5 (cg-RX-API-DMAC7.html)
HRP20200672T1 (hr) RNAi SREDSTVA, PRIPRAVCI I POSTUPCI NJIHOVE UPOTREBE ZA LIJEČENJE BOLESTI POVEZANIH S TRANSTIRETINOM (TTZ)
ES2753174T3 (es) Métodos de tratamiento de Síndrome de Alport
JP2021517126A5 (cg-RX-API-DMAC7.html)
FI4426270T3 (fi) Lipidi-nanopartikkelit oligonukleotidien kuljetusta varten
JP2017532038A5 (cg-RX-API-DMAC7.html)
AU2013235691B2 (en) Boronic acid conjugates of oligonucleotide analogues
JP2017525705A5 (cg-RX-API-DMAC7.html)
IL316808A (en) Modified double-stranded RNA materials and their uses
JP2021503941A5 (cg-RX-API-DMAC7.html)
RU2020135289A (ru) Применение ингибиторов fubp1 для лечения инфекции вирусом гепатита в
RU2011127079A (ru) Комбинация производного циклоспорина и нуклеозидов для лечения инфекции вирусом гепатита с
CA3057561A1 (en) Rna interference mediated inhibition of tmprss6
RU2020115761A (ru) МОЛЕКУЛЫ НУКЛЕИНОВЫХ КИСЛОТ ДЛЯ УМЕНЬШЕНИЯ УРОВНЯ мРНК PAPD5 ИЛИ PAPD7 ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИОННОГО ГЕПАТИТА В
JP2022533419A5 (cg-RX-API-DMAC7.html)
CN103492569A (zh) 碱基经修饰的寡核苷酸
JP2002534433A (ja) プロトン付加または酸性化された核酸および使用法
JP2024530956A5 (cg-RX-API-DMAC7.html)
CN115702006A (zh) 缀合基团及其缀合物
JPWO2021125311A5 (cg-RX-API-DMAC7.html)